Dr. Alexei L. Moraczewski, MD

Dr. Moraczewski practices at Advanced Eye Care in Orlando, Florida.

Dr. Moraczewski's NPI, 1659327849, was assigned on May 26, 2006. Dr. Moraczewski graduated from University of Miami, Miller School of Medicine in 2002. Dr. Moraczewski holds Florida license ME95715.

Dr. Moraczewski's primary practice is Advanced Eye Care, at 1911 N Mills Ave, Orlando, FL 32803 in Orange County. The practice phone is (407) 893-8200.

Dr. Moraczewski's primary practice is Advanced Eye Care in Orlando, Florida. Dmand AI also links Dr. Moraczewski to 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Moraczewski practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Moraczewski's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Moraczewski is board certified in ophthalmology by the American Board of Ophthalmology. Dr. Moraczewski is licensed in Florida.

Dmand AI lists cold sores or genital herpes, conjunctivitis, dry eye, eyelid inflammation, glaucoma, glaucoma surgery, hereditary corneal conditions and hypertensive retinopathy among the conditions Dr. Moraczewski treats.

CMS data shows 2,614 Medicare services from Dr. Moraczewski across 17 procedure codes in 2024, for 631 Medicare patients. Medicare paid $186,920 for them.

CMS counts 631 Medicare patients who saw Dr. Moraczewski in 2024. The largest group is 75 to 84, with 263 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.40, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Moraczewski's median patient age at 76, with 58% women.

In 2024, Dr. Moraczewski wrote 13,268 Medicare Part D claims for 1,974 patients. 75% of them were for generic drugs. CMS names the drug for 13,183 of them, across 37 drugs with 11 or more claims each, at $861,194 in total drug cost. In 2023, CMS named 13,449 claims across 40 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Moraczewski for performance year 2024, reported as part of a group. Dr. Moraczewski accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 18 procedures of cataract surgery by Dr. Moraczewski, more than 42% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Moraczewski in 2008. Dr. Moraczewski's most frequent co-authors are Richard K. Lee, MD, PhD, Paul F. Palmberg, MD and Philip J. Rosenfeld, MD.

CMS Open Payments shows 27 general payments to Dr. Moraczewski from 8 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 71% of the total. Shire North American Group Inc paid the most, $264.

Dr. Moraczewski graduated from University of Miami, Miller School of Medicine in 2002.

Dr. Moraczewski is in network with 18 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.